APVO
USDAptevo Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.510
Kõrge
$0.524
Madal
$0.450
Maht
0.03M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.8M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
2.91M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immune-oncology
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / April 4, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel
Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SEATTLE, WA / ACCESS Newswire / April 3, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immune-oncology
Seotud aktsiad
BMEZ
BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest
MCBS
MetroCity Bankshares Inc.
LGMK
LogicMark Inc. (NV)
MLP
Maui Land & Pineapple Company Inc.
IAS
Integral Ad Science Holding Corp.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.